196 related articles for article (PubMed ID: 25134433)
1. Variable NF-κB pathway responses in colon cancer cells treated with chemotherapeutic drugs.
Samuel T; Fadlalla K; Gales DN; Putcha BD; Manne U
BMC Cancer; 2014 Aug; 14():599. PubMed ID: 25134433
[TBL] [Abstract][Full Text] [Related]
2. Bromoethylindole (BEI-9) redirects NF-κB signaling induced by camptothecin and TNFα to promote cell death in colon cancer cells.
Chowdhury R; Gales D; Valenzuela P; Miller S; Yehualaeshet T; Manne U; Francia G; Samuel T
Apoptosis; 2017 Dec; 22(12):1553-1563. PubMed ID: 29116428
[TBL] [Abstract][Full Text] [Related]
3. RKIP phosphorylation and STAT3 activation is inhibited by oxaliplatin and camptothecin and are associated with poor prognosis in stage II colon cancer patients.
Cross-Knorr S; Lu S; Perez K; Guevara S; Brilliant K; Pisano C; Quesenberry PJ; Resnick MB; Chatterjee D
BMC Cancer; 2013 Oct; 13():463. PubMed ID: 24098947
[TBL] [Abstract][Full Text] [Related]
4. 3-(2-Bromoethyl)-indole inhibits the growth of cancer cells and NF-κB activation.
Fadlalla K; Elgendy R; Gilbreath E; Pondugula SR; Yehualaeshet T; Mansour M; Serbessa T; Manne U; Samuel T
Oncol Rep; 2015 Jul; 34(1):495-503. PubMed ID: 26063116
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of NF-kappaB signaling by quinacrine is cytotoxic to human colon carcinoma cell lines and is synergistic in combination with tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) or oxaliplatin.
Jani TS; DeVecchio J; Mazumdar T; Agyeman A; Houghton JA
J Biol Chem; 2010 Jun; 285(25):19162-72. PubMed ID: 20424169
[TBL] [Abstract][Full Text] [Related]
6. Lunasin potentiates the effect of oxaliplatin preventing outgrowth of colon cancer metastasis, binds to α5β1 integrin and suppresses FAK/ERK/NF-κB signaling.
Dia VP; Gonzalez de Mejia E
Cancer Lett; 2011 Dec; 313(2):167-80. PubMed ID: 21963225
[TBL] [Abstract][Full Text] [Related]
7. Curcumin enhances the effect of chemotherapy against colorectal cancer cells by inhibition of NF-κB and Src protein kinase signaling pathways.
Shakibaei M; Mobasheri A; Lueders C; Busch F; Shayan P; Goel A
PLoS One; 2013; 8(2):e57218. PubMed ID: 23451189
[TBL] [Abstract][Full Text] [Related]
8. Zuo Jin Wan reverses P-gp-mediated drug-resistance by inhibiting activation of the PI3K/Akt/NF-κB pathway.
Sui H; Pan SF; Feng Y; Jin BH; Liu X; Zhou LH; Hou FG; Wang WH; Fu XL; Han ZF; Ren JL; Shi XL; Zhu HR; Li Q
BMC Complement Altern Med; 2014 Aug; 14():279. PubMed ID: 25085593
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapy-induced CXC-chemokine/CXC-chemokine receptor signaling in metastatic prostate cancer cells confers resistance to oxaliplatin through potentiation of nuclear factor-kappaB transcription and evasion of apoptosis.
Wilson C; Purcell C; Seaton A; Oladipo O; Maxwell PJ; O'Sullivan JM; Wilson RH; Johnston PG; Waugh DJ
J Pharmacol Exp Ther; 2008 Dec; 327(3):746-59. PubMed ID: 18780829
[TBL] [Abstract][Full Text] [Related]
10. Chemotherapeutic Drugs Induce Different Gut Microbiota Disorder Pattern and NOD/RIP2/NF-κB Signaling Pathway Activation That Lead to Different Degrees of Intestinal Injury.
Huang B; Gui M; Ni Z; He Y; Zhao J; Peng J; Lin J
Microbiol Spectr; 2022 Dec; 10(6):e0167722. PubMed ID: 36222691
[TBL] [Abstract][Full Text] [Related]
11. Different effects of epigenetic modifiers on the cytotoxicity induced by 5-fluorouracil, irinotecan or oxaliplatin in colon cancer cells.
Ikehata M; Ogawa M; Yamada Y; Tanaka S; Ueda K; Iwakawa S
Biol Pharm Bull; 2014; 37(1):67-73. PubMed ID: 24172061
[TBL] [Abstract][Full Text] [Related]
12. Translationally controlled tumour protein TCTP is induced early in human colorectal tumours and contributes to the resistance of HCT116 colon cancer cells to 5-FU and oxaliplatin.
Bommer UA; Vine KL; Puri P; Engel M; Belfiore L; Fildes K; Batterham M; Lochhead A; Aghmesheh M
Cell Commun Signal; 2017 Feb; 15(1):9. PubMed ID: 28143584
[TBL] [Abstract][Full Text] [Related]
13. Calebin A Potentiates the Effect of 5-FU and TNF-β (Lymphotoxin α) against Human Colorectal Cancer Cells: Potential Role of NF-κB.
Buhrmann C; Kunnumakkara AB; Popper B; Majeed M; Aggarwal BB; Shakibaei M
Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32244288
[TBL] [Abstract][Full Text] [Related]
14. MSH3 mismatch repair protein regulates sensitivity to cytotoxic drugs and a histone deacetylase inhibitor in human colon carcinoma cells.
Park JM; Huang S; Tougeron D; Sinicrope FA
PLoS One; 2013; 8(5):e65369. PubMed ID: 23724141
[TBL] [Abstract][Full Text] [Related]
15. Codonopis bulleynana Forest ex Diels inhibits autophagy and induces apoptosis of colon cancer cells by activating the NF-κB signaling pathway.
Luan Y; Li Y; Zhu L; Zheng S; Mao D; Chen Z; Cao Y
Int J Mol Med; 2018 Mar; 41(3):1305-1314. PubMed ID: 29286074
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of the NF-κB pathway by nafamostat mesilate suppresses colorectal cancer growth and metastasis.
Lu YX; Ju HQ; Wang F; Chen LZ; Wu QN; Sheng H; Mo HY; Pan ZZ; Xie D; Kang TB; Chen G; Yun JP; Zeng ZL; Xu RH
Cancer Lett; 2016 Sep; 380(1):87-97. PubMed ID: 27322737
[TBL] [Abstract][Full Text] [Related]
17. The sirtuin inhibitor tenovin-6 upregulates death receptor 5 and enhances cytotoxic effects of 5-fluorouracil and oxaliplatin in colon cancer cells.
Ueno T; Endo S; Saito R; Hirose M; Hirai S; Suzuki H; Yamato K; Hyodo I
Oncol Res; 2013; 21(3):155-64. PubMed ID: 24512730
[TBL] [Abstract][Full Text] [Related]
18. Biglycan promotes the chemotherapy resistance of colon cancer by activating NF-κB signal transduction.
Liu B; Xu T; Xu X; Cui Y; Xing X
Mol Cell Biochem; 2018 Dec; 449(1-2):285-294. PubMed ID: 29761248
[TBL] [Abstract][Full Text] [Related]
19. Dauricine induces apoptosis, inhibits proliferation and invasion through inhibiting NF-kappaB signaling pathway in colon cancer cells.
Yang Z; Li C; Wang X; Zhai C; Yi Z; Wang L; Liu B; Du B; Wu H; Guo X; Liu M; Li D; Luo J
J Cell Physiol; 2010 Oct; 225(1):266-75. PubMed ID: 20509140
[TBL] [Abstract][Full Text] [Related]
20. Colon cancer cell chemosensitisation by fish oil emulsion involves apoptotic mitochondria pathway.
Granci V; Cai F; Lecumberri E; Clerc A; Dupertuis YM; Pichard C
Br J Nutr; 2013 Apr; 109(7):1188-95. PubMed ID: 22874769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
